GHRP-2: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข4 community protocols documented
- โขEvidence level: Structured Community Data
- โขBased on 110 community reports
- โข3 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Selectivity vs Potency Trade-off | Published studies demonstrate GHRP-2 produces potent GH release but with moderate cortisol and prolactin elevation. It has Japan regulatory approval as a GH deficiency diagnostic agent (GHRP Kaken). | Community recognizes GHRP-2 as more potent than ipamorelin but less selective. Users accept the cortisol/prolactin trade-off for stronger GH release, or prefer ipamorelin for cleaner selectivity. GHRP-2 is considered a middle ground between ipamorelin and GHRP-6. | moderate The community hierarchy of GHRPs (ipamorelin = most selective, GHRP-2 = balanced, GHRP-6 = most potent but least selective) is reasonably consistent with published pharmacological data. |
| Appetite Effects | Clinical studies note appetite stimulation as a ghrelin-mediated effect of GHRP-2, though less pronounced than GHRP-6. | Community reports moderate appetite increase with GHRP-2, positioned between the minimal appetite effect of ipamorelin and the intense hunger of GHRP-6. Some users specifically choose GHRP-2 for its appetite-stimulating properties during bulking phases. | low Community observations on appetite effects are consistent with the pharmacological profile and published clinical data. |
| Dosing Protocol | Clinical diagnostic use (Japan) involves single IV bolus doses. Research studies typically used IV administration at 1 mcg/kg. | Community uses subcutaneous injection at fixed doses of 100-200 mcg, typically 2-3 times daily with strict fasting protocols. | moderate The route (SubQ vs IV) and dosing approach (fixed vs weight-based) differ between clinical and community use. SubQ bioavailability relative to IV has not been well characterized for GHRP-2. |
Compare these community approaches with published research findings.
Community Protocols
Standard GH Release Protocol
Popular- Route
- Subcutaneous
- Dose
- 100-200 mcg
- Frequency
- 2-3 times daily
- Duration
- 8-12 weeks
Injected on empty stomach; fasting 1-2 hours before and 30-60 minutes after. Most common with GHRH analog.
GHRP-2 + GHRH Combo Protocol
Popular- Route
- Subcutaneous
- Dose
- 100 mcg GHRP-2 + 100 mcg Mod GRF 1-29
- Frequency
- 2-3 times daily
- Duration
- 8-16 weeks
Combined with GHRH analog for synergistic GH release; same saturation dose concept as ipamorelin stacks
Pre-Bed Only Protocol
Common- Route
- Subcutaneous
- Dose
- 200 mcg
- Frequency
- Once daily before bed
- Duration
- 8-12 weeks
Simplified protocol for those who want GH benefits without multiple daily injections
Appetite Stimulation Protocol
Niche- Route
- Subcutaneous
- Dose
- 100-200 mcg
- Frequency
- 30 minutes before meals, 2-3 times daily
- Duration
- 4-8 weeks
Leverages GHRP-2 appetite-stimulating properties; used by underweight individuals or those seeking caloric surplus
Stacking Patterns
GHRP-2 + CJC-1295 No DAC
PopularGHRP + GHRH synergy for enhanced pulsatile GH release; GHRP-2 provides stronger GH pulse than ipamorelin in this combination
GHRP-2 + Sermorelin
CommonAlternative GHRP + GHRH combination using FDA-approved GHRH analog; sermorelin as a more established GHRH option
GHRP-2 + Ipamorelin Rotation
NicheAlternating between GHRPs to prevent receptor desensitization; some users use GHRP-2 on training days and ipamorelin on rest days
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 110+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/Peptides|GHRP-2 experience reports and comparison with ipamorelin threads(accessed 2026-02-16)
- Reddit r/PeptideResearch|GHRP-2 protocol and dosing discussions(accessed 2026-02-16)
- Peptide Initiative|GHRP-2 Protocol and Dosing Guide(accessed 2026-02-16)
- Muscle and Brawn|GHRP-2 Peptide Guide (benefits, dosage, side effects)(accessed 2026-02-16)
- PeptideDosages.com|GHRP-2 5mg Vial Dosage Protocol(accessed 2026-02-16)
Community Evidence Overview#
This page presents aggregated community protocols and anecdotal reports for GHRP-2 (Pralmorelin). The information below is gathered from peptide research forums, Reddit communities, and self-experimenter reports. This is not clinical evidence and should not be used as medical guidance.
GHRP-2 occupies a specific niche in the GH secretagogue community as a balanced option between ipamorelin's selectivity and GHRP-6's potency. It is the only GHRP-class peptide with any regulatory approval (used as a GH deficiency diagnostic in Japan under the brand GHRP Kaken).
Understanding Protocol Divergence#
The GHRP Hierarchy#
The community has developed a clear hierarchy of GHRPs based on the selectivity-potency trade-off. Ipamorelin is considered the most selective (cleanest GH release), GHRP-2 is the balanced middle option, and GHRP-6 is the most potent but least selective (strongest appetite stimulation, more cortisol/prolactin). This ranking is broadly consistent with published pharmacological data.
Appetite as Feature or Bug#
GHRP-2's moderate appetite-stimulating effect is viewed differently by different community segments. Bodybuilders in bulking phases may specifically choose GHRP-2 for its appetite-enhancing properties, while those focused on fat loss or body recomposition may prefer ipamorelin to avoid increased food intake.
Commonly Reported Outcomes#
Community members frequently report the following when using GHRP-2:
- GH release: Perceived as stronger than ipamorelin, especially in combination with GHRH analogs
- Appetite increase: Moderate appetite stimulation within 30-60 minutes of injection
- Sleep quality: Improved sleep depth when dosed before bed
- Body composition: Gradual improvements over 2-4 months, similar to other GH secretagogues
- Recovery: Enhanced recovery from exercise, particularly when combined with GHRH analog
Important Caveats#
- Cortisol and prolactin elevation occurs with GHRP-2, unlike ipamorelin
- Most community users combine with GHRH analogs, making isolated attribution difficult
- Self-reported GH release potency comparisons lack objective measurement
- Product quality varies between vendors
Reconstitution and Storage Practices#
Community reconstitution practices for GHRP-2:
- Reconstitution: 1-2 mL bacteriostatic water per 5 mg vial
- Storage: Reconstituted solution refrigerated at 2-8 degrees C
- Shelf life: Most users report using reconstituted vials within 3-4 weeks
- Injection volume: Typically 0.02-0.1 mL per injection with insulin syringe
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Frequently Asked Questions About GHRP-2
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.